Immediate Impact
1 by Nobel laureates 1 from Science/Nature 64 standout
Citing Papers
Hepatocellular carcinoma: signaling pathways and therapeutic advances
2025 Standout
Targeted protein degradation: from mechanisms to clinic
2024 Standout
Works of Amy Tilley being referenced
FDA Approval: Ribociclib for the Treatment of Postmenopausal Women with Hormone Receptor–Positive, HER2-Negative Advanced or Metastatic Breast Cancer
2018
FDA Approval of Palbociclib in Combination with Fulvestrant for the Treatment of Hormone Receptor–Positive, HER2-Negative Metastatic Breast Cancer
2016
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Amy Tilley | 302 | 200 | 106 | 5 | 430 | |
| Jean-Christophe Eymard | 223 | 343 | 88 | 12 | 471 | |
| Anna Laura Aloisi | 305 | 78 | 92 | 6 | 459 | |
| James E. Krook | 294 | 134 | 48 | 9 | 421 | |
| Fernando Ortiz-Martínez | 219 | 77 | 77 | 12 | 417 | |
| Simonetta M. Leto | 374 | 147 | 58 | 9 | 481 | |
| Tanja Badovinac-Črnjević | 399 | 157 | 177 | 9 | 511 | |
| Sara Zaghlul | 260 | 126 | 100 | 8 | 489 | |
| James A. Onori | 211 | 226 | 34 | 4 | 478 | |
| Wei-Dong Wei | 186 | 181 | 71 | 12 | 413 | |
| Jimmy Pramana | 172 | 137 | 92 | 7 | 441 |
All Works
Loading papers...